GLICIA 40 (Gliclazide (40mg))

Glicia-40 is an oral medication that contains 40 mg of Gliclazide, which is classified as an oral hypoglycemic agent. It is primarily indicated for the management of type 2 diabetes mellitus. The mechanism of action involves stimulating the pancreas to enhance insulin secretion, which in turn aids in the reduction of blood glucose levels, particularly after meals. This medication is especially beneficial for individuals who have not achieved adequate glycemic control through diet and physical activity alone. Glicia-40 has a well-established safety profile and is effective in facilitating better diabetes management, assisting patients in reaching and sustaining optimal blood sugar levels. Regular monitoring of blood glucose is advised while using this medication, and it is important for patients to adhere to their prescribed treatment plan for optimal results. Additionally, lifestyle modifications such as maintaining a balanced diet and engaging in regular exercise remain crucial components of diabetes management alongside the use of Glicia-40. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.